-
-
-
-
-
-
-
Jaguar Health Provides Corporate Update and Outlines 2022 Milestones
-
-
-
-
-
-
-
Jaguar Health (JAGX) Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. and Dragon SPAC S.p.A.
-
-
-
-
-
-
-
Jaguar Health (JAGX) Announces Upsizing of At-the-Market Financing Program by $15.3 Million with Ladenburg Thalmann & Co. Inc. for Potential Future Financing Needs
-
-
-
-
-
-
-
Jaguar Health Announces Commitment to Move Forward with Exclusive Relationship with the Planned Dragon SPAC, which is Pursuing Listing on AIM Italia and Plans to Target Napo EU
-
-
-
-
-
-
-
Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar
-
-
-
-
-
-
-
Jaguar Health Strengthens Company's Balance Sheet by Reducing Approximately $10.5 Million of Debt Incurred to Effect 2017 Merger to Approximately $5.7 Million
-
-
-
-
-
-
-
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
-
1,160,151 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

